Compositions and methods for regulating receptor clustering
AssigneeMount Sinai Hospital
InventorsJim Dennis, Michael Demetriou
Life of this patent
Estimating the term…
Abstract
The invention relates to isolated complexes comprising one or more galectin associated with Mgat5 modified glycan or polylactosamine modified glycan, and isolated lectin-Mgt5 modified glycan lattice comprising an array of multivalent interactions among lectins, Mgat5 modified glycans, polylactosamine modified glycans, and/or glycoproteins. Methods for evaluating a test compound for its ability to regulate receptor clustering through glycans on cell surfaces; and methods for regulating receptor clustering on cell surfaces comprising altering glycans on the cell surface associated with receptor clustering are also discovered.
Claims4
A cell based assay for evaluating a test compound for its ability to regulate T cell receptor clustering comprising (a) providing T cells having galectin-3 associated with their T cell recptor and which are deficient in β1,6N-acetylglucosaminyltransferase V (Mgat5);
- (b) mixing the T cells, and a test compound under conditions which induce receptor clustering;
- (c) detecting receptor clustering;
- and (d) comparing to receptor clustering detected in T cells in the absence of a test compound wherein a difference in receptor clustering indicates that the test compound potentially regulates receptor clustering.
Dependencies are inferred from the claim text.